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Summary
Background: There are important gaps in our understanding of the epidemiology of respiratory
virus infections in tropical countries. In September 2003, the Colombian epidemiological sur-
veillance system was notified of several deaths from an acute respiratory disease (ARD).
Methods: In order to identify the agents associated with ARD cases, a clinical and laboratory-
based surveillance system was implemented throughout the country.
Results: Between September 19 and December 31, 2003, 64 suspected cases of ARD were
reported; of these reported cases, 21 (33%) died. Among 25 patients who underwent virus
studies, influenza A (H3N2) (n = 7) was the most frequently identified agent. Other viruses
included parainfluenza (4), influenza B (1), and respiratory syncytial virus (3). The peak
occurrence of cases and deaths coincided with the replacement of the influenza A (H3N2)
Panama strain, which had been circulating in Colombia since 1999, by three new influenza A
(H3N2) strains (Korea, Fujian, and Wyoming).
Conclusions: This outbreak led to the strengthening of surveillance for respiratory viruses and to
new national recommendations for influenza vaccination in Colombia.
# 2007 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.Introduction
The Colombian National Institute of Health (CNIH) has con-
ducted a laboratory-based surveillance system for respiratory
viruses (RV) since 1997. More than 2905 samples from sus-
pected cases of acute respiratory disease (ARD) were sub-
mitted for viral diagnosis between 1997 and 2002. Respiratory* Corresponding author.
E-mail address: fpdelahozr@unal.edu.co (F. de la Hoz).
1201-9712/$32.00 # 2007 International Society for Infectious Diseases.
doi:10.1016/j.ijid.2007.04.018syncytial viruses were the most frequent isolates (61%) asso-
ciated with respiratory syndromes, followed by influenza virus
(23%), adenovirus (5%), and parainfluenza viruses 1, 2, and 3
(5%).1,2
In temperate countries, the winter season is associated
with an increase in hospitalization rates for respiratory dis-
eases as well as with an increased risk of clinical complica-
tions among patients with chronic diseases or among children
under two years of age, most of whom have no underlying
diseases.3 However, in Colombia and other South American
and tropical countries there are still important gaps in thePublished by Elsevier Ltd. All rights reserved.
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Figure 1 Weekly distribution of acute respiratory disease
cases and deaths, September through December 2003; Colombia.understanding of the disease burden imposed by respiratory
viruses.4—6
In September 2003, the CNIH received reports of several
deaths among patients who had sought medical care for a
severe ARD. In order to determinewhether these deaths were
related to influenza virus or other respiratory agents, an
epidemiological alert was sent to the district health secre-
taries throughout the country with the aim of identifying
other cases of ARD. An additional goal of this initiative was to
improve the quality of the clinical and microbiological inves-
tigation of individual cases and to implement a more orga-
nized public health response to this and similar threats.
Methods
The national health system in Colombia is divided in 36 health
districts. All of themwere requested to notify the CNIH of any
increase in the number of patients with ARD. Each district
was also asked to pay special attention to adult patients with
severe ARD of short duration and to report these cases to the
CNIH.
The recommended definition for a suspected case of
severe ARD was a patient with fever and cough who devel-
oped a severe respiratory illness (high respiratory rate for
age, intercostal retractions, cyanosis) or any patient dying
with multi-lobar pneumonia or ARD of less than 10 days
duration. It was recommended that each suspected case
should be studied with a complete blood count, chest X-
ray, blood culture, and nasopharyngeal swab for virus isola-
tion. Medical officers were told that patients meeting these
criteria should be sent for further treatment to hospitals with
the highest level of medical technology available in the area.
When a suspected case was identified, local epidemiologists
were encouraged to complete an epidemiological surveil-
lance form and send it immediately to the CNIH by fax or e-
mail, and to promptly submit nasopharyngeal samples. The
clinical and epidemiological information collected from
patients included demographic data (age, sex, city of resi-
dence), clinical data (cough, respiratory distress, headache,
gastrointestinal symptoms, underlying diseases), clinical
diagnosis, duration of illness, clinical management, presence
of clinical complications, and patient status (alive or dead)
when discharged from hospital.
Specimens from the upper respiratory tract were obtained
with nasopharyngeal swabs, while samples from the lower
respiratory tract were obtained using bronchial washings. All
samples were refrigerated (4 8C) and sent to the CNIH virol-
ogy laboratory. For fatal cases, histological and pathological
specimens were obtained from lung, trachea, heart, brain,
liver, and kidney. Organ samples were preserved in paraffin or
formaldehyde and sent to the pathology laboratory at the
CNIH.
Respiratory samples from suspected ARD patients were
tested for viruses using Madin—Darby canine kidney tissue
cell cultures. If the presence of influenza virus was suggested
by occurrence of a cytopathic effect, the isolate was identi-
fied by hemagglutination inhibition (HAI) using the World
Health Organization (WHO) influenza reagent kit.7 Indirect
immunofluorescence (Light Diagnostics, Chemicon) was used
to identify other respiratory viruses.8 All laboratory work was
carried out in the virology laboratory of the National Institute
of Health in Bogota´. Quality control and strain identificationwere done by the influenza branch of the CDC in Atlanta, GA,
USA.
Data were stored in an EpiInfo 6.04 database and statis-
tical analyses of the epidemiological and clinical variables
were conducted using EpiInfo 3.3.2. We calculated the case
fatality rate (CFR, %) by age, gender, underlying disease, and
for viral agents when possible.
Results
Between September 19 and December 31, 2003, 64 suspected
cases of severe ARD were reported to the CNIH; of these
reported cases, 21 died (CFR = 33%). Cases were reported
from five of the 36 health districts, and most reports came
from the central area of the country. The peak period for case
reports was the six weeks from October 15 through November
30. Most of the 21 fatal cases occurred during the first week of
November. Of these, 16 died within seven days of the onset of
illness (Figure 1 and Table 1).
Severe ARD occurred in all age groups, but most cases
were concentrated in the group aged 15 to 44 years (n = 22,
34%), followed by those in the group aged 45 to 74 years
(n = 15, 23%). The highest case fatality rate (50%) was
observed among those aged 15 to 44 years. Cases were
evenly divided amongmen and women (32 each), but deaths
were more common among women (14) than men (7)
(Table 2).
Overall, the most common symptoms were cough (81%),
fever (78%), asthenia (78%), body pain (78%), and chest pain
(11%). Among patients who died, fever was themost frequent
symptom reported (17), followed by cough (16) and chest
pain (8).
Nine (14%) of 64 patients had underlying medical condi-
tions. Chronic respiratory disease (3) and high blood pressure
(3) were the most frequent diseases reported, followed by
ventricular—peritoneal shunt (1), active pulmonary tubercu-
losis (1), and coagulation disorder (1). Five out of nine cases
with underlying diseases died (CFR = 56%).
In 20 cases, accurate information was obtained on the
chest radiographs. The most frequently diagnosed pattern
was diffuse infiltrates (12) followed by multi-lobar pneumo-
nia (2), pneumothorax (1), diffuse opacity (1), and increased
bronchial markings (1). Three cases had normal chest radio-
graphs. Among the 21 fatal cases, chest radiographs were
available for ten. In this group, lung infiltrates were most
frequently observed (8), followed by multi-lobar pneumonia
(1) and a normal radiographic pattern (1).
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Table 1 Distribution of deaths by age group and days of illness
Days of illness Age groups (years) Total n Total %
<1 1—14 15—44 45—74 75
0—3 1 0 2 1 2 6 28.6
4—7 0 2 5 3 0 10 47.6
8—11 0 0 2 0 0 2 9.5
12—15 0 0 0 0 0 0 0
16—19 0 0 2 1 0 3 14.3
Total 1 2 11 5 2 21 100Local health services were able to collect adequate naso-
pharyngeal samples in 25 (39%) of the 64 cases. Using indirect
immunofluorescence, 13 of the 25 cases were virus-positive.
The most frequent virus found was influenza A (H3N2) (7),
followed by parainfluenza (4), respiratory syncytial virus (3),
and influenza B (1). In two cases, parainfluenza 1 was asso-
ciated with respiratory syncytial virus. Attempts were made
to identify respiratory viruses in eight (38%) of the 21 fatal
cases. Influenza A (H3N2) viruses were identified in three
cases, and the strains involved were Korea in two cases and
Wyoming in one. Influenza B and parainfluenza viruses wereTable 2 Distribution of acute respiratory disease and
deaths by age, sex, geographic area, and virological diagnosis
Deaths Cases Case fatality
ratio %
Age group (years)
<1 1 2 50
1—14 2 10 20
15—44 11 22 50
45—74 5 15 33
75 2 13 15
No data 0 2 0
Total 21 64 33
Sex
Female 14 32 44
Male 7 32 22
Total 21 64 33
Geographic area
Antioquia 6 21 28
Bogota´ 4 5 80
Caqueta´ 1 1 100
Cundinamarca 5 23 22
Norte de Santander 5 14 36
Total 21 64 33
Virus
Influenza A H3N2 3 7 43
Influenza B 1 1 100
Parainfluenza 1 1 2 50
Parainfluenza 1 + RSV 0 2 0
RSV 0 1 0
Negative 3 17 18
Total 8 32 25
RSV, respiratory syncytial virus.identified in one case each. Three cases were negative for
respiratory viruses.
Overall, clinical management included antimicrobial
treatment for 21 (35%) of 60 cases. Among the 21 cases that
died, only four (19%) received antibiotics. A post-mortem
examination was obtained for 10 of the 21 fatal cases. The
most frequent finding was bacterial pneumonia (6), followed
by interstitial pneumonitis (2) and diffuse alveolar damage
(2). Staphylococcus aureus was identified as the associated
agent in one case who died of bacterial pneumonia. No
further bacterial agent was isolated.
Discussion
The data in this report were obtained from a surveillance
system that was rapidly implemented during an outbreak of
severe ARD in a developing country. Pneumonia and influenza
are not systematically reported by the weekly surveillance
and epidemic alert system in Colombia, and therefore data
came mainly from areas with better surveillance systems
such as those in Bogota´, Antioquia, and Cundinamarca. These
regions represent about 20% of the Colombian population.
Less developed health districts were less able to provide
timely notification of cases.
Despite its shortcomings, this study provided Colombian
health officials with an initial estimate of the importance of
respiratory viruses as causal agents of severe ARD. For the
first time in 7 years, they were able to link information from
the sentinel surveillance system for respiratory viruses with
individual reports of severe ARD. Although data came from
only five of Colombia’s 36 health districts, they documented
that influenza viruses were circulating simultaneously in
several regions throughout the country. The data also sug-
gested that simultaneous circulation of several strains of
influenza A H3N2 virus (Panama, Korea, and Fujian serotypes)
could have been one of the reasons why severe cases were
more frequently reported during the influenza season.
Results from the surveillance network had earlier indicated
that influenza A (H3N2) Panama was the dominant strain that
circulated from June 1999 to September 2003, when it was
replaced by influenza A (H3N2) Fujian, Korea, and Wyoming
strains. As shown in Figure 2, the temporal peak of severe
cases and deaths coincided with the increase in circulation of
several strains of influenza A (H3N2) virus.
We were unable to compare the occurrences of similar
cases for preceding years since this was the first time that
such surveillance was implemented in the country. However,
we looked back at the overall mortality due to respiratory
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Figure 2 Weekly distribution of acute respiratory disease
cases, deaths, and influenza virus isolates, 2003; Colombia.diseases reported between years 2000 and 2004 for the
period between September and December in Bogota´ and
Cundinamarca, which were the areas reporting more cases
in this study. We found a 33% increase in deaths related to
respiratory causes during 2003, compared with the median
for the five years (1019 deaths vs. 819). This suggests that
there has been an overall increase in mortality that could be
due to the change observed in the strain of influenza virus.9
Similar to reports of other studies,3,6,7,10 our data con-
firmed that people with underlying chronic diseases, espe-
cially cardiopulmonary conditions, were at highest risk of
death during influenza seasons. This finding is not widely
known in tropical countries where surveillance systems for
respiratory viruses are weaker than those in more temperate
countries. The lack of a governmental vaccination policy was
another factor that could have contributed to the influenza-
related mortality of high-risk individuals. Prior to 2004, only
people who could pay for influenza vaccine were vaccinated,
and coverage rates were very low. However, in 2005 and
2006, health officials added influenza vaccination for people
older than 65 years and children under two years of age to the
national immunization program.
Colombian health officials have learned several lessons
from this experience. First, the laboratory network for influ-
enza surveillance was strengthened, andmore health depart-
ments acquired capabilities to isolate and characterize
influenza viruses. Currently, 10 departments report weekly
on the occurrence of suspected cases of influenza and the
laboratory results of active surveillance. Second, influenza
vaccination is now an integral part of the national immuniza-
tion program targeting children under two years of age,
adults over 65 years, and people with risk factors for severe
influenza-related disease.11 Finally, Colombia has launched a
program to strengthen its hospital networks in order to be
more prepared to deliver adequate medical care to peoplesuffering from ARD. The lessons learned from this experience
are relevant to other tropical and developing countries.
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